oral semaglutide launch Novo Nordisk has received FDA approval for Wegovy® (semaglutide) 25 mg, taken once daily, making it the first oral GLP-1 drug approved for obesity. Based on OASIS and SELECT trials, it LinkInBio | 💊📦 Diabetes care

Elevated prolactin can cause mood changes, libido issues, and even gynecomastia in men over time

So if it turns out my experiment works, and I can get my body used to its new weight, new waistline, and new metabolism by slowing drawing down my semaglutide dose, it'll be worth the extra time I'm spending tapering now.

All constructs and gene sequences used in this study were either commercially synthesised, generated by standard molecular cloning approaches or were generated in previous studies (Supplementary Information

Potenciacin de la Secrecin Insulnica: Tanto el GLP-1 como el GIP actan en conjunto para optimizar la respuesta insulnica, mejorando el control glucmico y reduciendo la resistencia a la insulina

I may be an N of one, but the evidence is more than anecdotal

Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society